Elanco Animal Health (ELAN) Common Equity (2017 - 2026)

Elanco Animal Health has disclosed Common Equity across 10 years of filings, most recently posting $6.6 billion for Q2 2026.

• In Q2 2026, Common Equity fell 2.76% year-over-year to $6.6 billion; the TTM figure through Jun 2026 stood at $6.6 billion (down 2.76% YoY), while the FY2025 annual figure was $6.5 billion, up 7.4% from the prior year.
• Common Equity came in at $6.6 billion for Q2 2026 at Elanco Animal Health, up from $6.5 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $7.6 billion in Q1 2022 to a low of $5.9 billion in Q2 2024.
• Average Common Equity over 5 years is $6.7 billion, with a median of $6.6 billion recorded in 2025.
• Year-over-year, Common Equity declined 19.92% in 2024 and rose 14.02% in 2025.
• Over 5 years, Common Equity stood at $7.3 billion in 2022, then dropped by 14.62% to $6.2 billion in 2023, then dropped by 2.04% to $6.1 billion in 2024, then climbed by 7.4% to $6.5 billion in 2025, then increased by 0.63% to $6.6 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $6.6 billion in Q2 2026, $6.5 billion in Q1 2026, and $6.5 billion in Q4 2025.